2-CCPA,
2-chloro-N(6)cyclopentyladenosine,
CCPA-2,
CCPA-2-chloro-N(6)-cyclopentyladenosine,
CCPA-2-Cl-N-CPA,
2-Chloro-N6-cyclopentyladenosine,
CCPA,
37739-05-2,
2-CHLORO-N-CYCLOPENTYLADENOSINE,
2-chloro-N(6)cyclopentyladenosine,
Adenosine, 2-chloro-N-cyclopentyl-,
BRN 4888162,
CHEMBL284969,
(2R,3R,4S,5R)-2-(2-chloro-6-(cyclopentylamino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol,
(2R,3R,4S,5R)-2-[2-chloro-6-(cyclopentylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol,
2-Chloro-N6-cyclopentyladenosine hemihydrate,
[3H]CCPA,
[3H]-CCPA,
C15H20ClN5O4,
ccpa (biochemistry),
AC1L3XBY,
2-Cl-CPA,
N6-Cyclopentyl-2-chloroAdo,
GTPL374,
GTPL379,
SCHEMBL120439,
2-(2-Chloro-6-cyclopentylamino-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol,
2-chloro-n6-cyclopentyl-adenosine,
XSMYYYQVWPZWIZ-IDTAVKCVSA-N,
HMS3676D14,
ZINC3995998,
4824AB,
BDBM50085658,
MFCD00078574,
PDSP1_000305,
PDSP1_000831,
PDSP1_001070,
PDSP2_000303,
PDSP2_000818,
PDSP2_001054,
AKOS016009595,
NCGC00025266-02,
AJ-47613,
AN-17019,
CC-10269,
LS-15108,
AX8016054,
DB-049183,
B6839,
FT-0639402,
2-chloro-N6-cyclopentyladenosine (2-Cl-CPA),
C-21110,
2-Chloro-N6-cyclopentyladenosine, adenosine receptor agonist,
2-(2-Chloro-6-cyclopentylamino-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol(CCPA),
(2R,3R,4S,5R)-2-(2-chloro-6-(cyclopentylamino)-9H-purin-9-yl)-5-(hydroxymethyl)-tetrahydrofuran-3,4-diol,
(2R,3R,4S,5R)-2-(2-Chloro-6-cyclopentylamino-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol,
(2R,3R,4S,5R)-2-[2-chloro-6-(cyclopentylamino)purin-9-yl]-5-(hydroxymethyl)tetrahydrofuran-3,4-diol,
CCPA-2-Cl-N-CPA,
2-CCPA,
CCPA-2,
D01LWZ,
D0R1XY,
C15-H20-Cl-N5-O4,
CID123807,
CCPA-2-chloro-N(6)-cyclopentyladenosine,
C058394,
5-(2-Chloro-6-cyclopentylamino-purin-9-yl)-tetrahydro-furan-2,3,4-triol,